GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines

#### Summary points Clinicians regularly face situations with two or more alternative actions. Each alternative often has different advantages and disadvantages, including differences in effectiveness, adverse effects, costs and other factors …

[1]  Andrew D Oxman,et al.  SUPPORT Tools for Evidence-informed Policymaking in health 18: Planning monitoring and evaluation of policies , 2009, Health Research Policy and Systems.

[2]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[3]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[4]  Christian Moser,et al.  User Experience Design , 2012 .

[5]  Richard Baker,et al.  A checklist for identifying determinants of practice: A systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice , 2013, Implementation Science.

[6]  S. Sorensen,et al.  A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation , 2013, PharmacoEconomics.

[7]  Elie A Akl,et al.  GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. , 2013, Journal of clinical epidemiology.

[8]  F. Cuoco.  Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial , 2011 .

[9]  G. Guyatt,et al.  Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[10]  Gerald Gartlehner,et al.  [GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[11]  H. Schünemann,et al.  [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.] , 2017, Recenti progressi in medicina.

[12]  P J Neumann,et al.  Systematic overview of cost-utility assessments in oncology. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Thomas Agoritsas,et al.  How to use a subgroup analysis: users' guide to the medical literature. , 2014, JAMA.

[14]  Sarah E. Rosenbaum,et al.  Improving the user experience of evidence : a design approach to evidence-informed health care , 2011 .

[15]  Christine Laine,et al.  Trustworthy Clinical Guidelines , 2011, Annals of Internal Medicine.

[16]  Gerald Gartlehner,et al.  [GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence]. , 2013, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[17]  Bjørn Hofmann,et al.  Different methods for ethical analysis in health technology assessment: An empirical study , 2011, International Journal of Technology Assessment in Health Care.

[18]  S. Athar.  Principles of Biomedical Ethics , 2011, The Journal of IMA.

[19]  P. Tugwell,et al.  Assessing equity in clinical practice guidelines. , 2007, Journal of clinical epidemiology.

[20]  David Rind,et al.  GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. , 2013, Journal of clinical epidemiology.

[21]  M. Tirani,et al.  [Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise]. , 2015, Recenti progressi in medicina.

[22]  Howard Balshem,et al.  GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.

[23]  W. Richardson,et al.  The well-built clinical question: a key to evidence-based decisions. , 1995, ACP journal club.

[24]  A. Oxman,et al.  Health Research Policy and Systems BioMed Central Review Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity , 2006 .

[25]  Elie A Akl,et al.  GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. , 2013, Journal of clinical epidemiology.

[26]  G. Guyatt,et al.  Going from evidence to recommendations , 2008, BMJ : British Medical Journal.

[27]  J. Richardson,et al.  A cost utility analysis of mammography screening in Australia. , 1992, Social science & medicine.

[28]  Sarah E. Rosenbaum,et al.  Developing and evaluating communication strategies to support informed decisions and practice based on evidence (DECIDE): protocol and preliminary results , 2013, Implementation Science.

[29]  K A McKibbon,et al.  Beyond ACP Journal Club: how to harness MEDLINE for prognosis problems. , 1995, ACP journal club.

[30]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[31]  Günter Ollenschläger,et al.  Guidelines International Network: Toward International Standards for Clinical Practice Guidelines , 2012, Annals of Internal Medicine.